Climb Bio (CLYM) Gains (Losses) on Sale of Assets & Investments (2021 - 2026)
Climb Bio (CLYM) posted Non Operating Investment Income of -$224,000 for Q2 2026, compared with $32,000 a year earlier.
Powered by 
Analysis
Climb Bio (CLYM) Gains (Losses) on Sale of Assets & Investments (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Investment Income at Climb Bio was -$385,000; for FY2025, it was $412,000.
- In prior years, Climb Bio's Non Operating Investment Income was $25,000 in FY2024 (-93.0%), $356,000 in FY2023, -$235,000 in FY2022 and -$123,000 in FY2021.
- Quarterly Non Operating Investment Income has run from a low of -$398,000 in Q1 2022 to a high of $263,000 in Q1 2025 over five years.
- According to Business Quant data, Non Operating Investment Income for the three prior quarters was -$278,000 (Q1 2026), -$34,000 (Q4 2025) and $151,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Climb Bio | 939.56 Mn | 340.37 Mn | - | -461,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -461,000.00 |
| Jun 30, 2026 | -224,000.00 |
| Mar 31, 2026 | -278,000.00 |
| Dec 31, 2025 | -34,000.00 |
| Sep 30, 2025 | 151,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 263,000.00 |
| Dec 31, 2024 | -178,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 223,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | -83,000.00 |
| Mar 31, 2022 | -398,000.00 |
| Dec 31, 2021 | -105,000.00 |
| Sep 30, 2021 | 18,000.00 |
API Access
Climb Bio Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CLYM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "CLYM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CLYM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();